nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetazolamide—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0699	0.282	CbGbCtD
Acetazolamide—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0472	0.19	CbGbCtD
Acetazolamide—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.045	0.182	CbGbCtD
Acetazolamide—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0402	0.162	CbGbCtD
Acetazolamide—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0236	0.0949	CbGbCtD
Acetazolamide—Myopia—Montelukast—chronic obstructive pulmonary disease	0.0224	0.0474	CcSEcCtD
Acetazolamide—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0222	0.0897	CbGbCtD
Acetazolamide—AQP1—respiratory system—chronic obstructive pulmonary disease	0.0143	0.0858	CbGeAlD
Acetazolamide—Excitement—Aminophylline—chronic obstructive pulmonary disease	0.0133	0.0283	CcSEcCtD
Acetazolamide—AQP1—connective tissue—chronic obstructive pulmonary disease	0.0126	0.0755	CbGeAlD
Acetazolamide—Metabolic acidosis—Formoterol—chronic obstructive pulmonary disease	0.0126	0.0267	CcSEcCtD
Acetazolamide—Metabolic acidosis—Arformoterol—chronic obstructive pulmonary disease	0.0126	0.0267	CcSEcCtD
Acetazolamide—Metabolic acidosis—Salbutamol—chronic obstructive pulmonary disease	0.0119	0.0252	CcSEcCtD
Acetazolamide—AQP1—bronchus—chronic obstructive pulmonary disease	0.0118	0.0706	CbGeAlD
Acetazolamide—AQP1—smooth muscle tissue—chronic obstructive pulmonary disease	0.0115	0.0691	CbGeAlD
Acetazolamide—AQP1—trachea—chronic obstructive pulmonary disease	0.0106	0.0634	CbGeAlD
Acetazolamide—CA3—respiratory system—chronic obstructive pulmonary disease	0.0105	0.0629	CbGeAlD
Acetazolamide—Excitement—Salbutamol—chronic obstructive pulmonary disease	0.00959	0.0203	CcSEcCtD
Acetazolamide—Appetite absent—Salbutamol—chronic obstructive pulmonary disease	0.00945	0.02	CcSEcCtD
Acetazolamide—CA3—connective tissue—chronic obstructive pulmonary disease	0.00925	0.0554	CbGeAlD
Acetazolamide—Growth retardation—Prednisone—chronic obstructive pulmonary disease	0.00864	0.0183	CcSEcCtD
Acetazolamide—CA7—trachea—chronic obstructive pulmonary disease	0.00847	0.0507	CbGeAlD
Acetazolamide—AQP1—lung—chronic obstructive pulmonary disease	0.00761	0.0456	CbGeAlD
Acetazolamide—CA12—respiratory system—chronic obstructive pulmonary disease	0.00744	0.0446	CbGeAlD
Acetazolamide—CA12—connective tissue—chronic obstructive pulmonary disease	0.00655	0.0392	CbGeAlD
Acetazolamide—Glycosuria—Formoterol—chronic obstructive pulmonary disease	0.00615	0.013	CcSEcCtD
Acetazolamide—Glycosuria—Arformoterol—chronic obstructive pulmonary disease	0.00615	0.013	CcSEcCtD
Acetazolamide—Injection site pain—Formoterol—chronic obstructive pulmonary disease	0.0061	0.0129	CcSEcCtD
Acetazolamide—Injection site pain—Arformoterol—chronic obstructive pulmonary disease	0.0061	0.0129	CcSEcCtD
Acetazolamide—CA1—respiratory system—chronic obstructive pulmonary disease	0.0059	0.0353	CbGeAlD
Acetazolamide—Glycosuria—Salbutamol—chronic obstructive pulmonary disease	0.00581	0.0123	CcSEcCtD
Acetazolamide—CA3—lung—chronic obstructive pulmonary disease	0.00558	0.0334	CbGeAlD
Acetazolamide—CA12—trachea—chronic obstructive pulmonary disease	0.0055	0.0329	CbGeAlD
Acetazolamide—Polyuria—Aminophylline—chronic obstructive pulmonary disease	0.00541	0.0115	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Roflumilast—chronic obstructive pulmonary disease	0.00519	0.011	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Aminophylline—chronic obstructive pulmonary disease	0.00491	0.0104	CcSEcCtD
Acetazolamide—Melaena—Formoterol—chronic obstructive pulmonary disease	0.00487	0.0103	CcSEcCtD
Acetazolamide—Melaena—Arformoterol—chronic obstructive pulmonary disease	0.00487	0.0103	CcSEcCtD
Acetazolamide—CA4—respiratory system—chronic obstructive pulmonary disease	0.00461	0.0276	CbGeAlD
Acetazolamide—Irritability—Aminophylline—chronic obstructive pulmonary disease	0.00454	0.00961	CcSEcCtD
Acetazolamide—Hypokalaemia—Aminophylline—chronic obstructive pulmonary disease	0.00432	0.00916	CcSEcCtD
Acetazolamide—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.0042	0.0089	CcSEcCtD
Acetazolamide—Ill-defined disorder—Roflumilast—chronic obstructive pulmonary disease	0.00398	0.00844	CcSEcCtD
Acetazolamide—CA12—lung—chronic obstructive pulmonary disease	0.00395	0.0237	CbGeAlD
Acetazolamide—Malaise—Roflumilast—chronic obstructive pulmonary disease	0.00387	0.0082	CcSEcCtD
Acetazolamide—CA2—respiratory system—chronic obstructive pulmonary disease	0.00382	0.0229	CbGeAlD
Acetazolamide—Thirst—Montelukast—chronic obstructive pulmonary disease	0.00372	0.00789	CcSEcCtD
Acetazolamide—Hypoglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.00371	0.00785	CcSEcCtD
Acetazolamide—Hypoglycaemia—Formoterol—chronic obstructive pulmonary disease	0.00371	0.00785	CcSEcCtD
Acetazolamide—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00361	0.00765	CcSEcCtD
Acetazolamide—CA5B—lung—chronic obstructive pulmonary disease	0.00355	0.0212	CbGeAlD
Acetazolamide—Hypoglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.0035	0.00741	CcSEcCtD
Acetazolamide—Haematuria—Aminophylline—chronic obstructive pulmonary disease	0.00349	0.0074	CcSEcCtD
Acetazolamide—CA4—trachea—chronic obstructive pulmonary disease	0.00341	0.0204	CbGeAlD
Acetazolamide—Irritability—Montelukast—chronic obstructive pulmonary disease	0.00338	0.00716	CcSEcCtD
Acetazolamide—CA2—connective tissue—chronic obstructive pulmonary disease	0.00336	0.0201	CbGeAlD
Acetazolamide—Hypokalaemia—Arformoterol—chronic obstructive pulmonary disease	0.00329	0.00697	CcSEcCtD
Acetazolamide—Hypokalaemia—Formoterol—chronic obstructive pulmonary disease	0.00329	0.00697	CcSEcCtD
Acetazolamide—Irritability—Salbutamol—chronic obstructive pulmonary disease	0.00326	0.00691	CcSEcCtD
Acetazolamide—Ataxia—Salbutamol—chronic obstructive pulmonary disease	0.00321	0.0068	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Montelukast—chronic obstructive pulmonary disease	0.00319	0.00676	CcSEcCtD
Acetazolamide—CA2—bronchus—chronic obstructive pulmonary disease	0.00315	0.0188	CbGeAlD
Acetazolamide—CA1—lung—chronic obstructive pulmonary disease	0.00313	0.0187	CbGeAlD
Acetazolamide—Hypokalaemia—Salbutamol—chronic obstructive pulmonary disease	0.00311	0.00659	CcSEcCtD
Acetazolamide—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00308	0.00653	CcSEcCtD
Acetazolamide—CA2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00308	0.0184	CbGeAlD
Acetazolamide—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.00305	0.00646	CcSEcCtD
Acetazolamide—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00304	0.00645	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00302	0.00641	CcSEcCtD
Acetazolamide—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00302	0.0064	CcSEcCtD
Acetazolamide—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00289	0.00612	CcSEcCtD
Acetazolamide—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00283	0.0251	CbGpPWpGaD
Acetazolamide—CA2—trachea—chronic obstructive pulmonary disease	0.00282	0.0169	CbGeAlD
Acetazolamide—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00278	0.0059	CcSEcCtD
Acetazolamide—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00273	0.00578	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.00271	0.00573	CcSEcCtD
Acetazolamide—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.00266	0.00563	CcSEcCtD
Acetazolamide—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.00266	0.00563	CcSEcCtD
Acetazolamide—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00263	0.00558	CcSEcCtD
Acetazolamide—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00263	0.00557	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.00258	0.00547	CcSEcCtD
Acetazolamide—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00251	0.00532	CcSEcCtD
Acetazolamide—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.00251	0.00532	CcSEcCtD
Acetazolamide—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00248	0.00525	CcSEcCtD
Acetazolamide—CA4—lung—chronic obstructive pulmonary disease	0.00245	0.0147	CbGeAlD
Acetazolamide—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.00244	0.00517	CcSEcCtD
Acetazolamide—Glycosuria—Prednisone—chronic obstructive pulmonary disease	0.00242	0.00513	CcSEcCtD
Acetazolamide—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.0024	0.00508	CcSEcCtD
Acetazolamide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—VEGFA—chronic obstructive pulmonary disease	0.00238	0.0211	CbGpPWpGaD
Acetazolamide—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00235	0.00498	CcSEcCtD
Acetazolamide—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00234	0.00495	CcSEcCtD
Acetazolamide—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.00232	0.00491	CcSEcCtD
Acetazolamide—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00232	0.00491	CcSEcCtD
Acetazolamide—Shock—Aminophylline—chronic obstructive pulmonary disease	0.0023	0.00487	CcSEcCtD
Acetazolamide—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00223	0.00472	CcSEcCtD
Acetazolamide—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.0022	0.00467	CcSEcCtD
Acetazolamide—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00219	0.00465	CcSEcCtD
Acetazolamide—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.00219	0.00465	CcSEcCtD
Acetazolamide—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00217	0.00459	CcSEcCtD
Acetazolamide—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.00213	0.00452	CcSEcCtD
Acetazolamide—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.00213	0.00452	CcSEcCtD
Acetazolamide—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00208	0.00441	CcSEcCtD
Acetazolamide—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00206	0.00436	CcSEcCtD
Acetazolamide—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00203	0.0043	CcSEcCtD
Acetazolamide—CA2—lung—chronic obstructive pulmonary disease	0.00203	0.0121	CbGeAlD
Acetazolamide—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.00202	0.00429	CcSEcCtD
Acetazolamide—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00202	0.00428	CcSEcCtD
Acetazolamide—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00202	0.00428	CcSEcCtD
Acetazolamide—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.00201	0.00427	CcSEcCtD
Acetazolamide—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.002	0.00424	CcSEcCtD
Acetazolamide—Agitation—Formoterol—chronic obstructive pulmonary disease	0.002	0.00424	CcSEcCtD
Acetazolamide—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00198	0.00419	CcSEcCtD
Acetazolamide—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00196	0.00416	CcSEcCtD
Acetazolamide—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00196	0.00416	CcSEcCtD
Acetazolamide—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00196	0.00415	CcSEcCtD
Acetazolamide—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00194	0.00411	CcSEcCtD
Acetazolamide—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00191	0.00404	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.0019	0.00403	CcSEcCtD
Acetazolamide—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00189	0.004	CcSEcCtD
Acetazolamide—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00186	0.00393	CcSEcCtD
Acetazolamide—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00185	0.00393	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—LEP—chronic obstructive pulmonary disease	0.00185	0.0164	CbGpPWpGaD
Acetazolamide—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00185	0.00392	CcSEcCtD
Acetazolamide—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00185	0.00391	CcSEcCtD
Acetazolamide—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00183	0.00388	CcSEcCtD
Acetazolamide—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00183	0.00388	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—TLR4—chronic obstructive pulmonary disease	0.00181	0.0161	CbGpPWpGaD
Acetazolamide—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00178	0.00377	CcSEcCtD
Acetazolamide—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00178	0.00377	CcSEcCtD
Acetazolamide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00175	0.00371	CcSEcCtD
Acetazolamide—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00174	0.00369	CcSEcCtD
Acetazolamide—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00173	0.00367	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—NOS2—chronic obstructive pulmonary disease	0.00173	0.0153	CbGpPWpGaD
Acetazolamide—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.0017	0.00361	CcSEcCtD
Acetazolamide—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00168	0.00356	CcSEcCtD
Acetazolamide—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00165	0.0035	CcSEcCtD
Acetazolamide—CA1—C-MYB transcription factor network—MPO—chronic obstructive pulmonary disease	0.00163	0.0144	CbGpPWpGaD
Acetazolamide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.0016	0.00339	CcSEcCtD
Acetazolamide—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00158	0.00335	CcSEcCtD
Acetazolamide—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00158	0.00335	CcSEcCtD
Acetazolamide—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00156	0.00332	CcSEcCtD
Acetazolamide—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00156	0.00332	CcSEcCtD
Acetazolamide—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00156	0.00331	CcSEcCtD
Acetazolamide—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00155	0.00328	CcSEcCtD
Acetazolamide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00154	0.00327	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00153	0.00325	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00153	0.00325	CcSEcCtD
Acetazolamide—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00153	0.00325	CcSEcCtD
Acetazolamide—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00153	0.00325	CcSEcCtD
Acetazolamide—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00153	0.00325	CcSEcCtD
Acetazolamide—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00151	0.00319	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.0015	0.00319	CcSEcCtD
Acetazolamide—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.0015	0.00318	CcSEcCtD
Acetazolamide—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00149	0.00316	CcSEcCtD
Acetazolamide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00148	0.00315	CcSEcCtD
Acetazolamide—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00148	0.00313	CcSEcCtD
Acetazolamide—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00146	0.0031	CcSEcCtD
Acetazolamide—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00146	0.0031	CcSEcCtD
Acetazolamide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00146	0.0031	CcSEcCtD
Acetazolamide—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00146	0.00309	CcSEcCtD
Acetazolamide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00146	0.00309	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00145	0.00307	CcSEcCtD
Acetazolamide—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00145	0.00307	CcSEcCtD
Acetazolamide—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00144	0.0127	CbGpPWpGaD
Acetazolamide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00141	0.00299	CcSEcCtD
Acetazolamide—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00141	0.00299	CcSEcCtD
Acetazolamide—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00141	0.00298	CcSEcCtD
Acetazolamide—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00141	0.00298	CcSEcCtD
Acetazolamide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.0014	0.00297	CcSEcCtD
Acetazolamide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00139	0.00294	CcSEcCtD
Acetazolamide—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00138	0.00293	CcSEcCtD
Acetazolamide—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00138	0.00293	CcSEcCtD
Acetazolamide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00138	0.00292	CcSEcCtD
Acetazolamide—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00138	0.00292	CcSEcCtD
Acetazolamide—Irritability—Prednisone—chronic obstructive pulmonary disease	0.00136	0.00288	CcSEcCtD
Acetazolamide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00133	0.00283	CcSEcCtD
Acetazolamide—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00133	0.00281	CcSEcCtD
Acetazolamide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00131	0.00277	CcSEcCtD
Acetazolamide—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.0013	0.00274	CcSEcCtD
Acetazolamide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00128	0.0027	CcSEcCtD
Acetazolamide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00128	0.0027	CcSEcCtD
Acetazolamide—AQP1—Metabolism—APIP—chronic obstructive pulmonary disease	0.00127	0.0112	CbGpPWpGaD
Acetazolamide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00125	0.00265	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	0.00123	0.0109	CbGpPWpGaD
Acetazolamide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00122	0.00258	CcSEcCtD
Acetazolamide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00122	0.00258	CcSEcCtD
Acetazolamide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.0012	0.00255	CcSEcCtD
Acetazolamide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00119	0.00252	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	0.00118	0.0105	CbGpPWpGaD
Acetazolamide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00118	0.00249	CcSEcCtD
Acetazolamide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00118	0.00249	CcSEcCtD
Acetazolamide—CA9—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.00117	0.0103	CbGpPWpGaD
Acetazolamide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00115	0.00244	CcSEcCtD
Acetazolamide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00243	CcSEcCtD
Acetazolamide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00113	0.00239	CcSEcCtD
Acetazolamide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00113	0.00239	CcSEcCtD
Acetazolamide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00111	0.00236	CcSEcCtD
Acetazolamide—Headache—Formoterol—chronic obstructive pulmonary disease	0.00111	0.00236	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	0.00111	0.00986	CbGpPWpGaD
Acetazolamide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.00235	CcSEcCtD
Acetazolamide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00111	0.00235	CcSEcCtD
Acetazolamide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.0011	0.00976	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—APIP—chronic obstructive pulmonary disease	0.0011	0.00975	CbGpPWpGaD
Acetazolamide—CA9—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.0011	0.00974	CbGpPWpGaD
Acetazolamide—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00109	0.00232	CcSEcCtD
Acetazolamide—Headache—Montelukast—chronic obstructive pulmonary disease	0.00109	0.00231	CcSEcCtD
Acetazolamide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00226	CcSEcCtD
Acetazolamide—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00106	0.00225	CcSEcCtD
Acetazolamide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00106	0.00224	CcSEcCtD
Acetazolamide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00106	0.00224	CcSEcCtD
Acetazolamide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00105	0.00223	CcSEcCtD
Acetazolamide—CA9—Cellular response to hypoxia—VEGFA—chronic obstructive pulmonary disease	0.00105	0.0093	CbGpPWpGaD
Acetazolamide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00219	CcSEcCtD
Acetazolamide—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00102	0.00217	CcSEcCtD
Acetazolamide—CA1—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	0.00102	0.00903	CbGpPWpGaD
Acetazolamide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000997	0.00211	CcSEcCtD
Acetazolamide—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000992	0.0021	CcSEcCtD
Acetazolamide—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000963	0.00204	CcSEcCtD
Acetazolamide—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000947	0.00201	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	0.000917	0.00813	CbGpPWpGaD
Acetazolamide—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000914	0.00194	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	0.0009	0.00797	CbGpPWpGaD
Acetazolamide—CA9—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000895	0.00792	CbGpPWpGaD
Acetazolamide—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000864	0.00183	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	0.000857	0.00759	CbGpPWpGaD
Acetazolamide—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000854	0.00757	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—SOD3—chronic obstructive pulmonary disease	0.000854	0.00756	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000841	0.00745	CbGpPWpGaD
Acetazolamide—CA9—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000834	0.00738	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—GC—chronic obstructive pulmonary disease	0.000818	0.00725	CbGpPWpGaD
Acetazolamide—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000795	0.00169	CcSEcCtD
Acetazolamide—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000793	0.00168	CcSEcCtD
Acetazolamide—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000788	0.00167	CcSEcCtD
Acetazolamide—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000773	0.00164	CcSEcCtD
Acetazolamide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000765	0.00162	CcSEcCtD
Acetazolamide—AQP1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000761	0.00674	CbGpPWpGaD
Acetazolamide—AQP1—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	0.000755	0.00669	CbGpPWpGaD
Acetazolamide—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000743	0.00157	CcSEcCtD
Acetazolamide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000742	0.00657	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000729	0.00646	CbGpPWpGaD
Acetazolamide—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000721	0.00153	CcSEcCtD
Acetazolamide—CA3—Metabolism—GC—chronic obstructive pulmonary disease	0.00071	0.00628	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—APIP—chronic obstructive pulmonary disease	0.00071	0.00628	CbGpPWpGaD
Acetazolamide—CA9—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000702	0.00622	CbGpPWpGaD
Acetazolamide—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.0007	0.00148	CcSEcCtD
Acetazolamide—CA6—Metabolism—APIP—chronic obstructive pulmonary disease	0.000691	0.00612	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—APIP—chronic obstructive pulmonary disease	0.000691	0.00612	CbGpPWpGaD
Acetazolamide—AQP1—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	0.000691	0.00612	CbGpPWpGaD
Acetazolamide—Shock—Prednisone—chronic obstructive pulmonary disease	0.000688	0.00146	CcSEcCtD
Acetazolamide—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000675	0.00598	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00066	0.00584	CbGpPWpGaD
Acetazolamide—AQP1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000652	0.00578	CbGpPWpGaD
Acetazolamide—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000647	0.00573	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—APIP—chronic obstructive pulmonary disease	0.000646	0.00572	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—APIP—chronic obstructive pulmonary disease	0.000646	0.00572	CbGpPWpGaD
Acetazolamide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000637	0.00135	CcSEcCtD
Acetazolamide—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000628	0.00133	CcSEcCtD
Acetazolamide—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000621	0.0055	CbGpPWpGaD
Acetazolamide—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000616	0.0013	CcSEcCtD
Acetazolamide—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000608	0.00129	CcSEcCtD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000606	0.00536	CbGpPWpGaD
Acetazolamide—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000603	0.00128	CcSEcCtD
Acetazolamide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000603	0.00128	CcSEcCtD
Acetazolamide—CA12—Metabolism—APIP—chronic obstructive pulmonary disease	0.000598	0.0053	CbGpPWpGaD
Acetazolamide—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000597	0.00529	CbGpPWpGaD
Acetazolamide—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000576	0.00122	CcSEcCtD
Acetazolamide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000572	0.00121	CcSEcCtD
Acetazolamide—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000556	0.00118	CcSEcCtD
Acetazolamide—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000553	0.00117	CcSEcCtD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00054	0.00478	CbGpPWpGaD
Acetazolamide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000539	0.00477	CbGpPWpGaD
Acetazolamide—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000518	0.00458	CbGpPWpGaD
Acetazolamide—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000502	0.00106	CcSEcCtD
Acetazolamide—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000491	0.00435	CbGpPWpGaD
Acetazolamide—CA9—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.000483	0.00428	CbGpPWpGaD
Acetazolamide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000479	0.00101	CcSEcCtD
Acetazolamide—CA4—Metabolism—APIP—chronic obstructive pulmonary disease	0.000477	0.00422	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00047	0.00416	CbGpPWpGaD
Acetazolamide—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000463	0.00098	CcSEcCtD
Acetazolamide—CA6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000458	0.00406	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000458	0.00406	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000457	0.00405	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—GC—chronic obstructive pulmonary disease	0.000457	0.00405	CbGpPWpGaD
Acetazolamide—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000451	0.00399	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000447	0.00396	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—GC—chronic obstructive pulmonary disease	0.000446	0.00395	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—GC—chronic obstructive pulmonary disease	0.000446	0.00395	CbGpPWpGaD
Acetazolamide—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000445	0.000942	CcSEcCtD
Acetazolamide—AQP1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000442	0.00391	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000438	0.00388	CbGpPWpGaD
Acetazolamide—Headache—Prednisone—chronic obstructive pulmonary disease	0.000438	0.000929	CcSEcCtD
Acetazolamide—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000434	0.00384	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000428	0.00379	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000428	0.00379	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000425	0.00376	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—GC—chronic obstructive pulmonary disease	0.000416	0.00368	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—GC—chronic obstructive pulmonary disease	0.000416	0.00368	CbGpPWpGaD
Acetazolamide—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000416	0.00088	CcSEcCtD
Acetazolamide—CA5A—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000414	0.00367	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000414	0.00367	CbGpPWpGaD
Acetazolamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000406	0.0036	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000403	0.00357	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000396	0.00351	CbGpPWpGaD
Acetazolamide—AQP1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000392	0.00347	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—GSTP1—chronic obstructive pulmonary disease	0.00039	0.00346	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000388	0.00343	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000387	0.00342	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000387	0.00342	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—GC—chronic obstructive pulmonary disease	0.000385	0.00341	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—APIP—chronic obstructive pulmonary disease	0.000385	0.00341	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000383	0.00339	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000372	0.00329	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000358	0.00317	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—CTGF—chronic obstructive pulmonary disease	0.00035	0.0031	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000322	0.00285	CbGpPWpGaD
Acetazolamide—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000319	0.00282	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000316	0.0028	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.00031	0.00274	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GC—chronic obstructive pulmonary disease	0.000307	0.00272	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000306	0.00271	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000303	0.00268	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GC—chronic obstructive pulmonary disease	0.000295	0.00261	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00029	0.00257	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000286	0.00253	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000285	0.00252	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GC—chronic obstructive pulmonary disease	0.000282	0.0025	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000274	0.00243	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00027	0.00239	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000269	0.00238	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000265	0.00235	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000264	0.00233	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000263	0.00233	CbGpPWpGaD
Acetazolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000258	0.00228	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000255	0.00226	CbGpPWpGaD
Acetazolamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000254	0.00225	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.00025	0.00221	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GC—chronic obstructive pulmonary disease	0.000248	0.0022	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000247	0.00219	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000247	0.00219	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000243	0.00216	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000243	0.00216	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000241	0.00213	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000241	0.00213	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000234	0.00207	CbGpPWpGaD
Acetazolamide—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000232	0.00205	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000231	0.00204	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000227	0.00201	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000227	0.00201	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000225	0.002	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000225	0.00199	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000225	0.00199	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—CTGF—chronic obstructive pulmonary disease	0.00022	0.00194	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—CTGF—chronic obstructive pulmonary disease	0.00022	0.00194	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000211	0.00186	CbGpPWpGaD
Acetazolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000209	0.00185	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000208	0.00184	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000208	0.00184	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000205	0.00182	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000205	0.00182	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000202	0.00179	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000202	0.00179	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—CXCL8—chronic obstructive pulmonary disease	0.000196	0.00174	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CTGF—chronic obstructive pulmonary disease	0.00019	0.00168	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000189	0.00167	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000189	0.00167	CbGpPWpGaD
Acetazolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000187	0.00166	CbGpPWpGaD
Acetazolamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000185	0.00164	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—ALB—chronic obstructive pulmonary disease	0.000184	0.00163	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000176	0.00155	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000175	0.00155	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000173	0.00153	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000171	0.00151	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000169	0.00149	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000169	0.00149	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000168	0.00149	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000166	0.00147	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000166	0.00147	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000166	0.00147	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000161	0.00143	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—VEGFA—chronic obstructive pulmonary disease	0.000159	0.00141	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000159	0.00141	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000159	0.00141	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—ALB—chronic obstructive pulmonary disease	0.000159	0.00141	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000158	0.0014	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000158	0.0014	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000155	0.00138	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000155	0.00138	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000155	0.00137	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000155	0.00137	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000154	0.00137	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000153	0.00135	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000152	0.00135	CbGpPWpGaD
Acetazolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000152	0.00134	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000151	0.00134	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000151	0.00134	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000147	0.0013	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000147	0.0013	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000146	0.00129	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000145	0.00129	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000145	0.00128	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000145	0.00128	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000144	0.00127	CbGpPWpGaD
Acetazolamide—SLC22A6—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.00014	0.00124	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00014	0.00124	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000139	0.00123	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000137	0.00122	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000137	0.00122	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000136	0.0012	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000134	0.00119	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000134	0.00119	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000134	0.00118	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000134	0.00118	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000132	0.00117	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000128	0.00114	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000127	0.00113	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000122	0.00108	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—TP53—chronic obstructive pulmonary disease	0.00012	0.00107	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000119	0.00105	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000116	0.00103	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000115	0.00102	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000113	0.000999	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000112	0.000988	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000111	0.000983	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—IL6—chronic obstructive pulmonary disease	0.00011	0.000976	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.00011	0.000974	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000109	0.000969	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000107	0.000947	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000107	0.000947	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000105	0.000934	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—ALB—chronic obstructive pulmonary disease	0.000103	0.000908	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000103	0.000908	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000101	0.000898	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—ALB—chronic obstructive pulmonary disease	9.99e-05	0.000885	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—ALB—chronic obstructive pulmonary disease	9.99e-05	0.000885	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.83e-05	0.000871	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—NOS3—chronic obstructive pulmonary disease	9.81e-05	0.000869	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.72e-05	0.000861	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—NOS3—chronic obstructive pulmonary disease	9.56e-05	0.000846	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—NOS3—chronic obstructive pulmonary disease	9.56e-05	0.000846	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.4e-05	0.000833	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—ALB—chronic obstructive pulmonary disease	9.33e-05	0.000826	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—ALB—chronic obstructive pulmonary disease	9.33e-05	0.000826	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.32e-05	0.000825	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.27e-05	0.000821	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	9.26e-05	0.00082	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	9.13e-05	0.000809	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—NOS3—chronic obstructive pulmonary disease	8.92e-05	0.00079	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—NOS3—chronic obstructive pulmonary disease	8.92e-05	0.00079	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.64e-05	0.000765	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—ALB—chronic obstructive pulmonary disease	8.64e-05	0.000765	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.51e-05	0.000753	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.39e-05	0.000743	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—NOS3—chronic obstructive pulmonary disease	8.27e-05	0.000732	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.19e-05	0.000726	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.06e-05	0.000714	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.95e-05	0.000704	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.13e-05	0.000632	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—ALB—chronic obstructive pulmonary disease	6.89e-05	0.00061	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—ALB—chronic obstructive pulmonary disease	6.61e-05	0.000585	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—NOS3—chronic obstructive pulmonary disease	6.59e-05	0.000584	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	6.49e-05	0.000575	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—ALB—chronic obstructive pulmonary disease	6.33e-05	0.000561	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—NOS3—chronic obstructive pulmonary disease	6.32e-05	0.00056	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.06e-05	0.000537	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ALB—chronic obstructive pulmonary disease	5.57e-05	0.000493	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—NOS3—chronic obstructive pulmonary disease	5.33e-05	0.000472	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.3e-05	0.000381	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	4.18e-05	0.00037	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.89e-05	0.000344	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.28e-05	0.000202	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	2.26e-05	0.0002	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	2.06e-05	0.000182	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.9e-05	0.000168	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.58e-05	0.00014	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.56e-05	0.000138	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.45e-05	0.000129	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.38e-05	0.000122	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	9.37e-06	8.3e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	8.97e-06	7.94e-05	CbGpPWpGaD
